Immunohistochemical analysis of normal and mutated ras oncogene p21 expression in human pulmonary and pleural neoplasms (original) (raw)
Immunohistochemical evaluation of ras oncogene expression in pulmonary and pleural neoplasms
Ann Thor
Virchows Archiv. B, Cell pathology including molecular pathology, 1987
View PDFchevron_right
Activated ras genes in pulmonary carcinoma
Manuel Perucho
Lung Cancer, 1988
View PDFchevron_right
Detection of RAS and RAS-associated alterations in primary lung adenocarcinomas. A correlation between molecular findings and tumor characteristics
Irfan Shaukat
Human pathology, 2018
View PDFchevron_right
Malignant Activation of a K-ras Oncogene in Lung Carcinoma but not in Normal Tissue of the Same Patient
Giuseppe della Porta
Science, 1984
View PDFchevron_right
K-ras gene mutational analysis supports a monoclonal origin of biphasic pleomorphic carcinoma of the lung
Antonio Iannucci
Modern Pathology, 2004
View PDFchevron_right
Detection of ras oncogenes by analysis of p21 proteins in human tumor cell lines
Jun Fujita
Urological Research, 1988
View PDFchevron_right
Mechanism of activation of an N-ras oncogene of SW-1271 human lung carcinoma cells
audrey chang
Proceedings of the National Academy of Sciences, 1984
View PDFchevron_right
Ras gene mutations in patients with non-small cell lung carcinoma
vojkan stanic
Archive of Oncology, 2004
View PDFchevron_right
Monoclonal antibodies that demonstrate specificity for several types of human lung cancer
Frank Cuttitta
Proceedings of the National Academy of Sciences, 1981
View PDFchevron_right
RAS ONCOGENES IN THE DIAGNOSIS OF HUMAN TUMOURS
George Sourvinos
View PDFchevron_right
Array comparative genomic hybridization-based characterization of genetic alterations in pulmonary neuroendocrine tumors
Jens Voortman, M. Suuriniemi
Proceedings of the National Academy of Sciences, 2010
View PDFchevron_right
RAS oncogenic activity predicts response to chemotherapy and outcome in lung adenocarcinoma
Julian Downward
Nature Communications
View PDFchevron_right
Dual role of RASSF1 as a tumor suppressor and an oncogene in neuroendocrine tumors of the lung
Giuseppe Viale
Anticancer research, 2010
View PDFchevron_right
Evaluation of napsin A, TTF-1, p63, p40, and CK5/6 immunohistochemical stains in pulmonary neuroendocrine tumors
Dafydd Thomas
American journal of clinical pathology, 2014
View PDFchevron_right
Murine Monoclonal Antibodies Raised against Human Non-Small Cell Carcinoma of the Lung: Specificity and Tumor Targeting1
Susan Chen
1990
View PDFchevron_right
Molecular and cellular biology of neuroendocrine lung tumors: Evidence for separate biological entities
Ernst-jan Speel
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2012
View PDFchevron_right
Overexpression of Oncoprotein 18 Correlates With Poor Differentiation In Lung Adenocarcinomas
Chiang-Ching Huang
Molecular & Cellular …, 2003
View PDFchevron_right
K-rasG12V mediated lung tumor models identified three new quantitative trait loci modifying events post-K-ras mutation
Noboru Suzuki
Biochemical and biophysical research communications, 2014
View PDFchevron_right
Identification of RASSF8 as a candidate lung tumor suppressor gene
Giacomo Manenti
Oncogene, 2006
View PDFchevron_right
Molecular Pathology of Lung Cancer
Alejandro Corvalan
Diagnostic Pathology of Pleuropulmonary Neoplasia, 2012
View PDFchevron_right
Monoclonal antibodies to a MUC 4 peptide react with lung cancer
Vasso Apostolopoulos
International Journal of Oncology, 1997
View PDFchevron_right
Oncogenic RAS activity predicts response to chemotherapy and outcome in lung adenocarcinoma
Julian Downward
bioRxiv, 2021
View PDFchevron_right
Expression of p21/sup ras/ in normal and malignant human tissues: lack of association with proliferation and malignancy
H. Niman
Pnas, 1987
View PDFchevron_right
Loss of heterozygosity at theRB locus correlates with loss of RB protein in primary malignant neuro-endocrine lung carcinomas
Christian Brambilla
International Journal of Cancer, 1994
View PDFchevron_right
Therapeutic Biomarkers in Lung Neuroendocrine Neoplasia
Ida Rapa
Endocrine Pathology, 2014
View PDFchevron_right
Activation of a human c-K-ras oncogene
Manuel Perucho
Nucleic Acids Research
View PDFchevron_right
Identification of genes differentially expressed in normal lung and non-small cell lung carcinoma tissue
Marco Colombi
Lung Cancer, 1995
View PDFchevron_right
Different types of K-Ras mutations could affect drug sensitivity and tumour behaviour in non-small-cell lung cancer
Eliana Rulli
Annals of Oncology, 2010
View PDFchevron_right
Tumor antigen on benign adenomas and on murine lung carcinomas quantitated by a two-site monoclonal antibody assay
Stephen Kennel
Cancer Research
View PDFchevron_right
Isolation of transforming sequences of two human lung carcinomas: structural and functional analysis of the activated c-K-ras oncogenes
Craig Neville, Manuel Perucho
Proceedings of the National Academy of Sciences, 1984
View PDFchevron_right
Two novel cell surface antigens on small cell lung carcinoma defined by mouse monoclonal antibodies NE-25 and PE-35
R. Namikawa
Cancer Research
View PDFchevron_right
Complex effects of Ras proto-oncogenes in tumorigenesis
Roberto Christian Díaz
Carcinogenesis, 2003
View PDFchevron_right
Genomic and Gene Expression Studies Helped to Define the Heterogeneity of Small-Cell Lung Cancer and Other Lung Neuroendocrine Tumors and to Identify New Therapeutic Targets
ugo testa
Onco
View PDFchevron_right